General surgery boards — boards outside the US.

11,400+ expert questions · 17 subspecialty boards

Prepare your surgical board with a surgeon.

A guideline-referenced question bank, an oral examination simulator that questions you back, and a study plan for your exact board. Written by a practising surgical oncologist — not a content agency.

No credit card · 50-question free trial · no auto-renewal

Created by Pablo Lozano Lominchar, MD, PhD, EBPSM · Surgical Oncologist

EUFEBS-SO
intermediate

A 51-year-old woman is evaluated for pseudomyxoma peritonei of appendiceal origin, confirmed on histology as low-grade mucinous adenocarcinoma. Computed tomography and diagnostic laparoscopy demonstrate a Peritoneal Cancer Index of 16, disease confined to the abdomen and no extra-abdominal spread. Performance status is ECOG 0. What is the most appropriate management?

Pick an answer to see the explanation — no account needed.
1 / 9 samples
Referenced to
NCCNESMOESSOPSOGIJGCA

11,400+

Questions

17

Boards

32,200

Answers logged

Free

Trial

Open results · updated 29 October 2026

What happened to the people who used it

Straight from the payment and usage records, not a marketing estimate. Test accounts and the author’s own account are left out.

  1. 42surgeons paid for a subscription

    At least one paid invoice. Free-trial accounts are not counted.

  2. 33have reached the end of it

    Their paid period is over — renewal is never automatic. 9 are still preparing.

  3. 29of those 33 have already sat their exam

    The exam date they gave us has passed. Their result is theirs to tell.

How much it was used

questions answered by subscribers

22,579

questions answered by subscribers

Every answer, every session, since launch.

questions per completed subscription

442

questions per completed subscription

The median: half of those who finished answered more.

days of study per subscriber

12

days of study per subscriber

Median number of days with at least one answered question.

surgeons have answered questions

126

surgeons have answered questions

32,200 answers in total, free trial included.

Why there is no pass rate here

After every exam date we ask the candidate how it went. 49 surveys sent, none answered so far. A pass rate nobody has reported would be invented, so we do not publish one. When the answers come in, they will appear here — whatever they say.

How it works

Built for how surgeons study

On the ward. Between cases. The night before the exam.

Board-specific

Filter by your exact exam. ABS, FEBS, MCh, TCBC and more — every question mapped to the official syllabus.

Instant feedback

Guideline-referenced explanations the moment you answer. Learn the reasoning, not just the key.

Weak-area focus

The engine tracks your accuracy and automatically resurfaces the topics you keep missing.

Study anywhere

Installs as an app on iPhone and Android. No app store, no friction — between cases or on the ward.

Live now

17 boards, 11,400+ questions

Every board links to its own guide: format, syllabus weighting and how many questions are ready for it.

Compare every board

Format, eligibility, syllabus weighting and preparation timeline — free, for every board.

Included with Pro

BETA

Rehearse the exam, not just the questions

Most candidates drill multiple-choice questions and then walk into an oral examination having never rehearsed one. The Exam Simulator closes that gap.

01

An examiner that questions you back

Clinical cases presented step by step. Answer vaguely and it probes further — exactly like a real viva. It also runs critical appraisals of recent randomised trials.

02

Your board’s real format

Oral-only vivas, OSCE stations, case-based written papers or timed multiple-choice — whichever your board actually uses, with its real timing.

03

A scored report at the end

A verdict plus domain scores for clinical reasoning, guideline knowledge, decision-making and communication — and what to study next.

Oral examination · stage 1 of 414:22

EXAMINER

A 43-year-old woman presents with erythema and peau d’orange over more than a third of the right breast. Skin punch biopsy shows dermal lymphatic invasion; core biopsy reveals ER−/PR−/HER2+ invasive ductal carcinoma. Staging is negative for distant disease.

What is her clinical TNM stage, and what is the recommended initial management?

YOU

I would proceed to surgery.

EXAMINER

Surgery will be part of her care, but we must stage the disease and decide the sequence of therapy first. What T category does dermal lymphatic invasion correspond to — and what does that change about the order of treatment?
Ends with a scored report: verdict, domain scores and what to study next.

Pricing

Deliberately affordable

Start free. Upgrade when you’re ready. No renewal happens unless you choose it.

Every paid plan includes the Exam Simulator beta

No auto-renewal — your subscription simply ends · Cancel nothing, pay nothing more
Last-minute review — out now on Kindle and in paperback

Margin Clear

The last-minute review for surgical oncology boards

The book to read in the last weeks before the ABS-CGSO or the European Board of Surgical Oncology (FEBS-SO / EBSQ) — when there is no time left to reread a textbook and what you need is the whole syllabus in the shape the examiner will ask it.

Not an atlas and not a formulary: the framework of judgement behind a cancer operation, in 574 printed pages you can work through section by section. Every chapter follows the same predictable shape — epidemiology, TNM staging, diagnosis, surgical management, systemic therapy, landmark trials, board pearls and common pitfalls — so you can go straight to the gap you need to close. Integrated with NCCN 2026 and ESMO 2024.

  • Ten anatomic sections, from general principles to skin and melanoma
  • 239 single-best-answer questions with fully worked answers, plus a timed final test of 60
  • Landmark trials in structured format — CROSS, FLOT4, ESOPEC, Z0011, AMAROS and more
  • Consolidated AJCC 8th edition staging appendix
Margin Clear — Surgical Oncology Board Review, front cover

Pablo Lozano Lominchar, MD, PhD, EBPSM  ·  Luis González Bayón, MD, PhD
with Juan Carbonel, MD  ·  First edition, Madrid 2026
Paperback 574 pages  ·  ISBN 979-8192960059

From the people using it
“Wonderful app, it has everything you need to study, review and prepare for the exam to certify your consultant title in the United Arab Emirates”
Miguel Angel Steiner · Spain  ·  27 August 2026  ·  verified on Trustpilot
“My preparation is going wonderfully. Highly recommended.”
ML · Spain  ·  18 August 2026  ·  verified on Trustpilot

Read every review on Trustpilot · Leave one yourself

Roadmap

Expanding globally

More boards in the pipeline. Get one email when yours launches.

JSGSJSHBPSCMO-SOABHS-SO

One email when your board goes live. No spam.

Your certification is coming.
Start today.

Join surgical consultants and fellows across Europe, North America, the Middle East and India preparing for subspecialty certification.

No credit card · 50-question free trial

FAQ

Frequently asked questions

What is SurgBoardsQ&A?+

SurgBoardsQ&A is a surgical board exam preparation platform with 11,400+ clinical vignette MCQs covering 17 subspecialty surgical certification exams across seven countries, from the ABS-CGSO in the United States and the FEBS/EBSQ boards in Europe to the Saudi Commission fellowships, the Indian MCh/DrNB and the Brazilian SBCO. All questions are referenced to current guidelines (NCCN, ESMO, ESSO, PSOGI).

Which surgical board exams does SurgBoardsQ&A cover?+

SurgBoardsQ&A currently covers 17 boards: FEBS-SO — FEBS Surgical Oncology (7,411 questions); FEBS-HPB — FEBS Hepatopancreatobiliary Surgery (3,087 questions); FEBS-Colo — FEBS — Coloproctology (1,609 questions); FEBS-Endo — FEBS — Endocrine Surgery (1,946 questions); FEBS-Breast — FEBS Breast Surgery (1,490 questions); FEBS-ECS — FEBS Esophago-Gastric Cancer Surgery (1,362 questions); FEBS-MBS — FEBS Metabolic and Bariatric Surgery (1,049 questions); FEBS-TS — FEBS Transplant Surgery (1,549 questions); ABS-CGSO — American Board of Surgery – Complex General Surgical Oncology (7,411 questions); ABCRS — American Board of Colon and Rectal Surgery (1,168 questions); ASTS/TACC — Abdominal Transplant Surgery Certification (ASTS / TACC) (1,549 questions); MBS FPD — Metabolic and Bariatric Surgery Focused Practice Designation (ABS / ASMBS) (1,049 questions); ACTPS FPD — Adult Complex Thyroid and Parathyroid Surgery Focused Practice Designation (ABS / ABOHNS) (850 questions); SCFHS-CRS — Saudi Fellowship in Colon and Rectal Surgery (1,609 questions); SCFHS-EBS — Saudi Fellowship in Endocrine and Breast Surgery (3,008 questions); MCh-SO — MCh / DrNB Surgical Oncology — India (NMC universities / NBEMS) (7,352 questions); SBCO — Título de Especialista em Cirurgia Oncológica — Sociedade Brasileira de Cirurgia Oncológica (7,340 questions). The Indian MCh board covers both the MCh and the DrNB routes. Boards in development include JSGS, JSHBPS, CMO-SO, ABHS-SO.

Who creates the questions on SurgBoardsQ&A?+

All questions are written by Dr. Pablo Lozano Lominchar, MD, PhD, EBPSM — a surgical oncologist specializing in peritoneal malignancy and retroperitoneal sarcoma.

Is there a free trial?+

Yes. SurgBoardsQ&A offers a free tier with 50 questions at no cost, with no credit card required. Pro access is $100 for three months or $300 for a year, with unlimited questions across all 17 boards.

Are the questions referenced to current guidelines?+

Yes. Every explanation cites the relevant guideline source: NCCN, ESMO, ESSO, PSOGI, JGCA, or the landmark RCT underpinning the answer. The question bank is updated when major guidelines change.

SurgBoardsQ&A

Every surgical board. One question bank. Board-referenced practice questions written by surgical oncologists.

SurgBoardsQ&A is an independent educational resource. It is not affiliated with, endorsed by, sponsored by or accredited by any examining or certifying body. The European Board of Surgery and UEMS, the American Board of Surgery, the National Board of Examinations in Medical Sciences, the Sociedade Brasileira de Cirurgia Oncológica, the National Comprehensive Cancer Network, the European Society for Medical Oncology, the European Society of Surgical Oncology and the Peritoneal Surface Oncology Group International are the trade marks of their respective owners and are referred to here for identification purposes only. Guideline content is summarised in our own words; no guideline text is reproduced.

© 2026 Dr. Pablo Lozano Lominchar · SurgBoardsQ&A